by Xcellerant Ventures | Sep 24, 2024 | Portfolio Company News, Xcellerant Ventures News
Origionally posted on Business Wire: https://www.businesswire.com/news/home/20240924360690/en/Xcellerant-Ventures-Leads-DeepLook-Medical%E2%80%99s-Series-A-Round SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant Ventures is proud to announce that it will lead...
by Xcellerant Ventures | Jan 12, 2024 | Portfolio Company News, Xcellerant Ventures News
Why Xcellerant Ventures Invested in CRISPR QC The Xcellerant Venture’s team is proud to lead a Series A funding round for CRISPR QC, the San Diego-based biotechnology company that has developed the world’s first and only CRISPR Analytics Platform. This platform...
by Xcellerant Ventures | Jan 6, 2024 | Xcellerant Ventures News
Origionally posted on Business Wire: https://www.businesswire.com/news/home/20240105587000/en/Xcellerant-Ventures-Ends-First-Year-with-10th-Investment-Leading-CRISPR-QC%E2%80%99s-10-Million-Series-A-Round SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant...
by Xcellerant Ventures | Dec 20, 2023 | Portfolio Company News, Xcellerant Ventures News
Why Xcellerant Ventures Invested in Lenoss Medical The Xcellerant Venture’s team proudly welcomes Lenoss Medical as our 9th portfolio company in Xcellerant Ventures Fund 1. The enthusiasm surrounding their groundbreaking technology is nothing short of exhilarating. In...
by Xcellerant Ventures | Dec 13, 2023 | Portfolio Company News, Xcellerant Ventures News
Origionally posted on Business Wire: https://www.businesswire.com/news/home/20231213775926/en/Xcellerant-Ventures-Invests-in-Series-A-Funding-Round-for-Lenoss-Medical SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant Ventures welcomes Lenoss Medical into our...
by Xcellerant Ventures | Oct 27, 2023 | Xcellerant Ventures News
Content origionally posted on Glue Up’s YoutTube: https://www.youtube.com/watch?v=A55JPAlPkcE With the significant tightening in the market for VC financing, there have been meaningful changes in deal terms and bargaining power between startup companies and the...
